Quince Therapeutics, Inc. (QNCX)

1.37 +0.10 (+7.87%) USD  |  NASDAQ  |  Apr 21, 16:00
1.34 -0.03 (-2.19%) After-Hours: 20:00
More

Quince Therapeutics Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for QNCX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. Upgrade
Ocular Therapeutix, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Ernexa Therapeutics, Inc. Upgrade
Acurx Pharmaceuticals, Inc. Upgrade